fda semaglutide shortage resolved 2025 announcement The Ozempic Is Over September 15, 2025: Telehealth company
Description
With the highest 12 mg dose of retatrutide (Eli Lilly) an investigational #GLP1, glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptor agonist nearly two-thirds of participants lost 20% or more of their body weight, half of participants lost 25% of their body weight and one-quarter of participants lost more than 30% of their body weight
It works by mimicking the action of Glucagon-like Peptide-1 (GLP-1), promoting insulin secretion, inhibiting glucagon secretion, and delaying gastric emptying, which helps control blood sugar levels and aids in weight loss
Includes medication, clinician care, 1:1 coaching & Noom Weight program
Grateful if you can share this
